Polymer formulations of cetp inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/16 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2641451

A pharmaceutical composition comprises (a) a CETP inhibiting compound, or a pharmaceutically acceptable salt thereof; (b) a concentration-enhancing polymer; and (c) optionally one or more surfactants; wherein the compound has the structure shown as Formula I below. The composition raises HDL-cholesterol and lowers LDL-cholesterol.

La présente invention concerne une composition pharmaceutique comprenant (a) un composé d'inhibition de CETP, ou sel dérivé pharmaceutiquement acceptable, (b) un polymère d'amélioration de concentration et (c), en option, au moins un tensioactif, sachant que le composé a la structure affichée dans la Formule I ci-dessous. La composition augmente le cholestérol HDL et diminue le cholestérol LDL.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polymer formulations of cetp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymer formulations of cetp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer formulations of cetp inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1615570

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.